Presented by: Jacob Svoboda, MD
The Abramson Cancer Center of the University of Pennsylvania
Last Modified: May 9, 2013
Learn about current treatments and emerging therapies for Hodgkin's Lymphoma management in this insightful video featuring Jakub Svoboda, MD, Assistant Professor in the Division of Hematology/Oncology, at the Abramson Cancer Center of the University of Pennsylvania.
Watch the video presentation by Dr. Svoboda, which will open in a new window.
This video presentation was made possible by an unrestricted educational grant from our sponsor, Seattle Genetics, Inc.*
* All materials created by OncoLink are educational and non-promotional in nature and are prepared, designed and executed in accordance with the U.S. Food and Drug Administration Guidance on Industry-Supported Scientific and Educational Activities ("Policy Statement"). The OncoLink Editorial Staff creates this content independently and without control or influence by our sponsors over the materials. We are committed to educating the public while keeping our content free of commercial bias for or against any product; our sponsors may not require OncoLink or the Abramson Cancer Center of the University of Pennsylvania to accept advice or services concerning speakers, authors, participants or other education matters, including content. The OncoLink Editorial Team will ensure that any product discussions in the content will be objective, balanced and scientifically rigorous. This includes a balanced discussion of the product and of treatment alternatives, limitations on data will be disclosed, and unapproved uses will be identified as such.
Aug 28, 2014 - Para-aortic radiation correlates with increased diabetes mellitus risk for Hodgkin's lymphoma survivors, according to a study published online Aug. 25 in the Journal of Clinical Oncology.
Aug 28, 2014